Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides

Virology

Volumn 257, Issue 1, 1999, Pages 177-190

  Chang, J C ^a   Seidel, C ^b   Ofenloch, B ^b   Jue, D L ^a   Fields, H A ^a   Khudyakov, Y E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PEPTIDE; PROTEIN;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME IMMUNOASSAY; GENETIC HETEROGENEITY; GENOTYPE; HEPATITIS C VIRUS; IMMUNOREACTIVITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0033602560     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9612     Document Type: Article

References (52)

1. Adams N. J., Chamberlain R. W., Taylor L. A., Davidson F., Lin C. K., Elliott R. M., Simmonds P. Complete coding sequence of hepatitis C virus genotype 6a. Biochem. Biophys. Res. Commun. 234:1997;393-396.
2. Alonso C., Qu D., Lamelin J. P., De Sanjose S., Vitvitski L., Li J., Berby F., Lambert V., Cortey M. L., Trepo C. Serological responses to different genotypes of hepatitis C virus in France. J. Clin. Microbiol. 32:1994;211-212.
3. Barany G., Merrifield R. B. The Peptides. 1980;Academic Press, New York. p. 1-284.
4. Berasain C., Garcia-Granero M., Riezu-Boj J., Civeira M. P., Prieto J., Borras-Cuesta F. Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides. J. Hepatol. 18:1993;80-84.
5. Bhattacherjee V., Prescott L. E., Pike I., Rodgers B., Bell H., El-Zayadi A. R., Kew M. C., Conradie J., Lin C. K., Marsden H., Saeed A. A., Parker D., Yap P-L., Simmonds P. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5, and 6. J. Gen. Virol. 76:1995;1737-1748.
6. Bukh J., Miller R. H., Purcell R. H. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes. Semin. Liver Dis. 15:1995;41-63.
7. Cerino A., Mondelli M. U. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies. J. Immunol. 147:1991;2692-2696.
8. Chamberlain R. W., Adams N., Saeed A. A., Simmonds P., Elliott R. M. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J. Gen. Virol. 78:1997;1341-1347.
9. Chan S. W., McOmish F., Holmes E. C., Dow B., Peutherer J. F., Follett E., Yap P. L., Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73:1992;1131-1141.
10. Chan S. W., Simmonds P., McOmish F., Yap P. L., Mitchell R., Dow B., Follett E. Serological responses to infection with three different types of hepatitis C virus. Lancet. 338:1991;1391.
11. Chaudhary R. K., Frenette S., Mo T. Evaluation of hepatitis C virus kits. J. Clin. Microbiol. 29:1991;2616-2617.
12. Chayama K., Tsubota A., Koida I., Arase Y., Saitoh S., Ikeda K., Kumada K. Nucleotide sequence of hepatitis C virus (type 3b) isolated from a Japanese patient with chronic hepatitis C. J. Gen. Virol. 75:1994;3623-3628.
13. Chiba J., Ohba H., Matsuura Y., Atanabe Y., Katayama T., Kikuchi S., Saito I., Miyamura T. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc. Natl. Acad. Sci. USA. 88:1991;4641-4645.
14. Chien D. Y., Choo O. L., Tabrizi A., Kuo C., McFarland J., Berger K., Lee C., Shuster J. R., Nguyen T., Moyer D. L. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: Reevaluation of the role of HCV in liver disease. Proc. Natl. Acad. Sci. USA. 89:1992;10011-10015.
15. Choo Q., Kuo G., Weiner A., Overby L., Bradley D., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
16. Choo Q.-L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Goit D., Medina-Selby A., Barr P. J., Weiner A. J., Bradley D. W., Kuo G., Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;2451-2455.
17. Dhaliwal S. K., Prescott L. E., Dow B. C., Davidson F., Brown H., Yap P. L., Follett E. A. V., Simmonds P. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J. Med. Virol. 48:1996;184-190.
18. Dusheiko G., Schmilovitz-Weiss H., Brown D., McOmish F., Yap P. L., Sherlock S. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology. 19:1994;13-18.
19. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993;1385-1395.
20. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
21. Hosein B., Fang C. T., Popovsky M. A., Ye J., Zhang M., Wang C. Y. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc. Natl. Acad. Sci. USA. 88:1991;3647-3651.
22. Houghton M., Weiner A., Han J. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
23. Inoue Y., Suzuki R., Matsuura Y., Harda S., Chiba J., Eatanabe Y., Saito I., Miyamura T. Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases. J. Gen. Virol. 73:1992;2151-2154.
24. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohroshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;9524-9528.
25. Khudyakov Y. E., Khudyakova N. S., Jue D. L., Lambert S. B., Fang S., Fields H. A. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology. 206:1995;666-672.
26. Kuo G., Choo Q.-L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E., Tegtmeier G. E., Bonino F., Colombo M., Lee W.-S., Huo C., Berger K., Shuster J. R., Overby L. R., Bradley D. W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
27. Machida A., Ohnuma H., Tsuda F., Munekata E., Tanaka T., Akahane Y., Okamoto H., Mishiro S. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology. 16:1992;886-891.
28. McOmish F., Chan S. W., Dow B. C., Gillon J., Frame W. D., Crawford R. J., Yap P. L., Follett E. A. C., Simmonds P. Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 33:1993;7-13.
29. McOmish F., Yap P. L., Dow B. C., Follett E. A. C., Seed C., Keller A. J., Cobain T. J., Krusius T., Kolho E., Naukkarinen R., Lin C., Lai C., Leong S., Medgyesi G. A., Nejjas M., Kiyokawa H., Fukada K., Cuypers T., Saeed A. A., Al-Rasheed A. M., Lin M., Simmonds P. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J. Clin. Microbiol. 32:1994;884-892.
30. Miller R. H., Purcell R. H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus subgroups. Proc. Natl. Acad. Sci. USA. 87:1990;2059-2061.
31. Mori S., Ohkoshi S., Hijikata M., Kato N., Shimotohno K. Serodiagnostic assay of hepatitis C virus infection using viral protease expressed inEscherichia coli. Jpn. J. Cancer Res. 83:1992;264-268.
32. Muraiso K., Hijikata M., Ohkoshi S., Cho M. J., Kikuchi M., Kato N., Shimotohno K. A structural protein of hepatitis C virus expressed inE. coli. Biochem. Biophys. Res. Commun. 172:1990;511-516.
33. Nagayama R., Tsuda F., Okamoto H., Wang Y., Mitsui T., Tanaka T., Miyakawa Y., Mayumi M. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C 100-3 protein. J. Clin. Invest. 92:1993;1529-1533.
34. Nasoff M. S., Zebedee S. L., Inchauspe G., Prince A. M. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;5462-5466.
35. Neri P., Bonci A., Campoccia G., Fanetti G., Lozzi L., Scarselli M., Soldani P. Antigenicity of synthetic peptides derived from C100 protein of hepatitis C virus. Arch. Virol. Suppl. 4:1992;186-190.
36. Okamoto H., Kurai K., Okada S.-I., Yamamoto K., Lizuka H., Tanaka T., Fukuda S., Tsuda F., Mishiro S. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology. 188:1992;331-341.
37. Pujol F. H., Khudyakov Y. E., Devesa M., Leon G., Blitz-Dorfman L., Monsalve F., Lambert S. B., Kalinina T. Y., Liprandi F., Fields H. A. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome. Viral Immunol. 9:1996;89-96.
38. Riezu-Boj J. I., Parker D., Civeira M. P., Phoppard D., Corbishley T. P., Camps J., Castilla A., Prieto J. Detection of hepatitis C virus antibodies with new recombinant antigens: Assessment in chronic liver diseases. J. Hepatol. 15:1992;309-313.
39. Sallberg M., Ruden U., Wahren B., Magnius L. O. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J. Clin. Microbiol. 30:1992;1989-1994.
40. Simmonds P. Variability of hepatitis C virus. Hepatology. 21:1995;570-583.
41. Simmonds P., Holmes E. C., Cha T. A., Chan S.-W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74:1993a;2391-2399.
42. Simmonds P., Rose K. A., Graham S., Chan S.-W., McOmish F., Dow B. C., Follett E. A. C., Yap P. L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J. Clin. Microbiol. 31:1993b;1493-1503.
43. Stuyver L., Van Arnhem W., Wyseur A., Maertens G. Cloning and phylogenetic analysis of the core, E2, and NS3/NS4 regions of the hepatitis C virus type 5a. Biochem. Biophys. Res. Commun. 202:1994;1308-1314.
44. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65:1991;1105-1113.
45. Takeuchi K., Kubo Y., Boonmar Y., Waranabe Y., Katayama T., Choo Q. L., Kuo G., Houghton M., Saito E., Miyamura T. The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J. Gen. Virol. 71:1990;3027-3033.
46. Van Der Poel C. L., Cuypers H. T. M., Reesink H. W., Weiner A. J., Quan S., Di Nello R., Van Boven J. J. P., Winkel I., Mulder-Folkerts D., Exel-Oehers P. J., Schaasberg W., Leentvaar-Kuypers A., Polito A., Houghton M., Lelie P. N. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 337:1991;317-319.
47. Wienhues U., Ihlenfeldt H.-G., Seidel C., Schmitt U., Kraas W., Jung G. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies. Virology. 245:1998;281-288.
48. Yuki N., Hayashi N., Kasahara A., Hagiwara H., Ueda K., Fusamoto H., Kamada T. Antibodies to a putative hepatitis C virus polyprotein in Japanese patients with chronic liver disease. J. Med. Virol. 38:1992;86-91.
49. Zein N. N., Germer J. J., Wendt N. K., Schimek C. M., Thorvilson J. N., Mitchell P. S., Persing D. H. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: Significance of high-level c22-3 reactivity and influence of HCV genotypes. J. Clin. Microbiol. 35:1997;311-312.
50. Zein N. N., Rakela J., Persin D. H. Genotype-dependent serologic reactivities patients infected with hepatitis C virus in the United States. Mayo Clin. Proc. 70:1995;449-452.
51. Zhang Z. X., Chen M., Sonnerborg A., Sallberg M. Antigenic structure of the complete nonstructural NS2 and NS5 proteins of hepatitis C virus (HCV): Anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection. Clin. Diagn. Lab. Immunol. 1:1994;290-294.
52. Zhang Z. X., Yun Z., Chen M., Sonnerborg A., Sallberg M. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: Relation to genomic typing by the polymerase chain reaction. J. Med. Virol. 45:1995;50-55.